Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Thomas Jefferson University
City of Hope Medical Center
Universität des Saarlandes
Insel Gruppe AG, University Hospital Bern
University of Washington
Georgetown University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Columbia University
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Fondazione Italiana Linfomi - ETS
Stanford University
M.D. Anderson Cancer Center
Imperial College London
Academic and Community Cancer Research United
University of Rochester
City of Hope Medical Center
University of California, San Francisco
Duke University
University of Chicago
University of Colorado, Denver
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Stanford University
Mayo Clinic
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
University of Nebraska
University of Nebraska
OHSU Knight Cancer Institute
University of Southern California
University of Pennsylvania
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Imperial College London